Lysine-specific histone demethylase 1A (LSD1) in cervical cancer

12Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Purpose: Demethylation of DNA through enzymes like LSD1 showed a crucial impact on different kind of cancers. Epigenetic modifications in cervical cancer are still not fully investigated nevertheless of high interest for a therapeutic use. Methods: Tumor samples of 250 cervical cancer patients were immunochemically stained and evaluated based on Immunoreactive Score. Results were statistically analyzed for clinical and pathological parameters. Results: Our patient collective showed a disadvantage for 10-year survival for patients with a strong expression of LSD1 in the cytoplasm of cervical cancer cells. The results of the correlational analysis further revealed a negative correlation of LSD1 to G-protein coupled estrogen receptor (GPER). Conclusions: Epigenetic changes through enzymes like LSD1 may also be of interest for patients with cervical cancer. A combined therapy with other proteins relayed to cervical cancer like GPER might be of interest for future investigations.

Cite

CITATION STYLE

APA

Beilner, D., Kuhn, C., Kost, B. P., Jückstock, J., Mayr, D., Schmoeckel, E., … Heidegger, H. H. (2020). Lysine-specific histone demethylase 1A (LSD1) in cervical cancer. Journal of Cancer Research and Clinical Oncology, 146(11), 2843–2850. https://doi.org/10.1007/s00432-020-03338-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free